Download PDF

Other users also viewed these articles

Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study Roxana González Mazarío; Jorge Juan Fragío Gil; José Ivorra Cortés; Elena Grau García; Antonio José Cañada Martínez; Luis González Puig; Rosa María Negueroles Albuixech; José Andrés Román Ivorra;
Reumatol Clin. 2022;18:523-30
Associated factors to health-related quality of life in anti-neutrophil cytoplasmic antibodies-associated vasculitis patients: Data from the Almenara Vasculitis Cohort Allison Milagros Figueroa-Sánchez; Leonor Stefani León-Yaurimucha; Manuel F. Ugarte-Gil; Victor R. Pimentel-Quiroz;
Reumatol Clin. 2025;21:
VEXAS syndrome: A 2-case series report Adrián Mayo-Juanatey; María José Fernández-Llavador; María del Mar Fernández-Garcés; Elia Valls-Pascual; Juan José Alegre-Sancho;
Reumatol Clin. 2024;20:341-4